<![CDATA[Parkinson’s disease (PD) diagnosis and monitoring have significantly improved because to current advancements in artificial intelligence (AI), particularly in the areas of deep learning (DL) and machine learning (ML). Early-stage insensitivity of traditional diagnostic techniques necessitates the use of clever, data-driven alternatives. AI-powered noninvasive diagnostic methods like speech recognition, handwriting analysis, and neuroimaging categorization are the main topic of this technical review. We provide a summary of comparative performance measures from recent models, highlighting their practical usefulness, data modality, and accuracy. Also covered are important issues like data variability, real-world implementation, and model interpretability. Unlike prior surveys that primarily report accuracy metrics, this review explicitly focuses on identifying the gap between experimental AI performance and real-world clinical deployment, emphasizing interpretability, validation, and scalability challenges in PD diagnosis. The purpose of this letter is to provide guidance for researchers creating deployable and clinically valid AI systems for PD detection.]]>
Copyrights © 2026
